Outcomes and toxicities following stereotactic ablative radiotherapy for pulmonary metastases in patients with primary head and neck cancer.

Dario PasalicSonia L Betancourt-CuellarNicolette TakuEthan Bernard LudmirYi LuPamela K AllenChad TangMara B AntonoffClifton David FullerDavid I RosenthalWilliam H MorrisonJack PhanAdam S GardenJames W WelshJoe Y ChangZhongxing LiaoJeremy J ErasmusQuynh-Nhu Nguyen

Published in: Head & neck (2020)

Metastatic pulmonary HNCs after SABR have a two-year OS rate comparable to pulmonary metastasectomy.

Keyphrases

pulmonary hypertension
early stage
small cell lung cancer
radiation therapy
metabolic syndrome
insulin resistance
brain metastases